Venture • Life Science

Eight Roads Invests In Adcentrx Therapeutics

On April 24, 2023, private equity firm Eight Roads invested in life science company Adcentrx Therapeutics

Investment Context
  • This is Eight Roads’ 73rd transaction in the Life Science sector.
  • This is Eight Roads’ 119th transaction in the United States.
  • This is Eight Roads’ 42nd transaction in California.

Explore All 557 Venture Life Science Deals - Search the Database Free


Investment Summary

Date April 24, 2023
Target Adcentrx Therapeutics
Sector Life Science
Investor(s) Eight Roads
Deal Type Venture

Target Company

Adcentrx Therapeutics

San Diego, California, United States
Adcentrx Therapeutics is a biotechnology company focused on accelerating breakthroughs in protein conjugate therapeutic development for cancer and other life-threatening diseases. Adcentrx Therapeutics was founded in 2021 and is based in San Diego, California.
Explore More Deals

Browse All 215,158 Deals

FILTER BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Search Free

Investor Overview 1

Investor

Eight Roads

Investor Investor Investor Investor Investor


Category Private Equity Firm
Founded 1969
PE ASSETS 11.0B USD
Size Mega
Type Sector Focused
DESCRIPTION

Eight Roads is a private investment firm focused on a variety of investment opportunities across the US, Europe, and Asia. The Firm is divided into several investment strategies including venture, principal investing, and real estate. Within the principal investments group, Eight Roads backs established growth businesses with long-term capital. Eight Roads does not have any sector preferences, but has experience in fintech, business services, and healthcare. Eight Roads is based in London.


Deal Context for Investor #
Overall 293 of 293
Sector: Life Science 73 of 73
Type: Venture 266 of 266
State: California 42 of 42
Country: United States 119 of 119
Year: 2023 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2023-03-17 LakeShore Bio

Beijing, China

LakeShore Bio is a biopharmaceutical company, researches, develops, manufactures, and markets immuno-oncology products and vaccines. LakeShore Bio was founded in 1994 and is based in Beijing, China

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2023-04-25 Medwell Ventures

Bangalore, India

Medwell Ventures provides specialty home healthcare services in India. It focuses on various therapeutic areas. The company offers various wellness and care programs ranging from preventive screening to home healthcare and palliative care. It provides bedside nursing care at home, as well as 24×7 medical services, such as physician consultation, nursing care, laboratory sample collection and reporting, physiotherapy, medical devices, ambulance services, pharmacy support, and related medical services. Medwell Ventures was founded in 2014 and is based in Bangalore, Karnataka.

Sell -